Patient Group Pushes FDA For LASIK Ban
Executive Summary
A group of patient advocates including one former US FDA official met with agency staff on Sept. 13 to raise awareness about adverse events tied to LASIK surgery. The group said the vision-correcting procedure is too risky to be offered as elective surgery.
You may also be interested in...
LASIK Comments Show Divided Opinions As FDA Extends Feedback Period
The comment period for a draft guidance document on labeling for LASIK surgery equipment has been extended for another month. Ninety people have already filed comments, representing a wide range of views about the procedure.
Tool For Evaluating LASIK Outcomes Gets FDA Qualification
The US FDA has qualified a tool used to assess patient outcomes of LASIK surgery as scientifically valid. The qualification aims to support the agency’s pre- and post-market regulatory decisions and aid manufacturers in the development of devices for the procedure.
US FDA Issues New Patient-Reported Outcome Tools For LASIK
The agency posted questionnaires that it says can be used to help eye-care professionals assess patients before and after LASIK surgery and can be used by device manufacturers to support product submissions.